Venture Houston 2018
Skip Content

29 June 2018

Helix seals $200m series B round

The personal genomics product supplier has closed a round featuring corporates Illumina and Mayo Clinic after receiving funding from Temasek.

Author: Robert Lavine, News Editor

US-based personal genomics platform operator Helix closed a series B round featuring genomics technology producer Illumina and medical research and services provider Mayo Clinic at $200m yesterday.